Loading clinical trials...
Loading clinical trials...
Descriptive Pharmacoepidemiological Study on the Use of Symbicort Turbuhaler in the Treatment of Asthma in France and Impact of a New Therapeutic Strategy on the Compliance and Control of Asthma
Conditions
Locations
168
France
Research Site
Dessenheim, Alsace, France
Research Site
Duppigheim, Alsace, France
Research Site
Haguenau, Alsace, France
Research Site
Obernai, Alsace, France
Research Site
Schiltigheim, Alsace, France
Research Site
Strasbourg, Alsace, France
Start Date
April 1, 2009
Primary Completion Date
March 1, 2011
Completion Date
August 1, 2011
Last Updated
December 29, 2011
NCT02327897
NCT07219173
NCT07486401
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions